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Background: Epicutaneous sensitization with protein allergen that induces predominant Th2 responses is an
important sensitization route in atopic dermatitis. Fungal components have been shown to modulate Th cell
differentiation. However, the effects of fungal components on epicutaneous sensitization are unclear.
Results: In this study, we showed that co-administration of curdlan, a dectin-1 agonist, during epicutaneous
ovalbumin sensitization of BALB/c mice decreased the IL-5 and IL-13 levels in supernatants of lymph node cell
ovalbumin reactivation cultures. Mechanistically, curdlan co-administration decreased IL-4 and IL-1β expressions in
draining lymph nodes. Curdlan co-administration also lower the migration of langerin+ CD103- epidermal
Langerhans cells into draining lymph nodes at 96 hours post-sensitization which might be attributed to decreased
expressions of IL-18 and IL-1β in patched skin. Moreover, adoptive transfer of CFSE-labeled transgenic CD4 T cells
confirmed that curdlan co-administration decreased the proliferation and IL-4-production of ovalbumin -specific T
cells primed by epidermal Langerhans cells.
Conclusions: These results indicated that concurrent exposure to a dectin-1 agonist suppresses the epicutaneously
induced Th2 response by modulating the cytokine expression profiles in draining LNs and the migration of
epidermal Langerhans cells. These results highlight the effects of fungal components on epicutaneous allergen
sensitization in atopic diseases.
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The prevalence of atopic diseases has progressively
increased in recent decades. The interaction between
genetic susceptibility for atopy with varying environmen-
tal allergen exposures plays a central role in the patho-
genesis of atopic diseases [1]. Allergens that provoke
atopic diseases are ubiquitously distributed environmen-
tal protein antigens. Atopic dermatitis (AD) is often the
first manifestation of the atopic triad and typically marks
the onset of the “atopic march” [2].
The route of protein allergen sensitization in AD
remains unclear. However, compelling clinical evidence
suggests that epicutaneous exposure to protein antigen* Correspondence: lifangwa@ntu.edu.tw
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reproduction in any medium, provided the oris one of the important sensitization routes for AD [3,4].
In animal models, we and others have demonstrated that
epicutaneous sensitization with protein antigens induces
predominate Th2 and weak Th1 responses, which leads
to AD-like skin lesions and the development of asthma
[5,6]. Epicutaneous sensitization with protein antigen
also induces a modest Th17 response [7,8]. However,
cross-priming with an epicutaneously introduced protein
antigen generates Th1, but not Th2 cells [9]. An epicuta-
neously induced Th2 response requires the production
of IL-10 and IL-13 [10,11]. Because defective IFN-γ pro-
duction during infancy may be an important cause for
sustained elevation of Th2 responses in atopic children,
determining how to suppress Th2 and/or promote Th1
responses during the early sensitization period was. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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course of atopic diseases [12].
Severe systemic fungal infections have become an in-
creasing problem during recent decades. The cell walls of
fungi are composed, primarily, of carbohydrates, including
mannoprotein, β-glucan, and chitin, which can be recog-
nized by several classes of pattern recognition receptors
[13]. Among these, dectin-1, a C-type lectin receptor
involved in the recognition of β-glucan was shown to be
crucial for the control of fungal infection [14,15]. Dectin-1
signaling in macrophages and neutrophils can trigger
phagocytosis, a respiratory burst, and the production of
inflammatory cytokines and chemokines, which further
activate macrophages and neutrophils, thus resulting in
the elimination of microorganisms [16]. Moreover, these
pattern recognition receptors can drive the development
of adaptive immunity. For example, signaling through
dectin-1 induces dendritic cell (DC) maturation with the
concomitant upregulation of co-stimulatory molecules
and the secretion of IL-2, IL-10, IL-6, and TNF-α, in
addition to a bias for IL-23 production rather than IL-12
[17]. Dectin-1-activated DCs can instruct the differenti-
ation of Th1 and Th17, but not Th2 cells [17,18]. Stimula-
tion of DCs via the dectin-1 pathway also allows priming
of cytotoxic T-cell responses [19].
Many fungi, such as Candida albicans, are both com-
mensals and pathogens at the skin surface and mucosa. In
addition, cutaneous superficial dermatophyte infections are
very common in subtropical and tropical regions. Thus, the
effects of concurrent exposure to fungal components on
epicutaneous sensitization with protein antigen need to be
explored. Curdlan is a pure (1–3) β-glucan in triple helix
form that can specifically activate dectin-1 signaling [17]. In
this study, we demonstrate that concurrent curdlan expos-
ure can suppress the predominate Th2 response induced
by epicutaneous sensitization with protein antigen.
Methods
Mice and reagents
Eight to 12-week-old female BALB/c mice were purchased
from the animal center of National Taiwan University Col-
lege of Medicine and maintained in a specific pathogen-
free environment. All animal experiments were approved
by the animal care committee of the Medical Collage of
National Taiwan University. Ovalbumin (OVA) (Grade V)
was purchased from Sigma-Aldrich (St Louis, Mo) and cur-
dlan was from Wako (Richmond, VA). Pam3CSK4 and
zymosan were from InvivoGen (Carlsbad, CA). Capture
and biotin-conjugated detection antibodies against IFN-γ
and IL-5 used for ELISAs were from PharMingen (San
Diego, CA). Streptavidin-alkaline phosphatase was from
Southern Biotechnology (Birmingham, AL). A murine IL-
13 ELISA kit (R&D Systems, Minneapolis, MN) and IL-17
ELISA kit (eBioscience) were used for determinations ofIL-13 and IL-17 in cell culture supernatants. Antibodies for
flow cytometry were from PharMingen, e-Bioscience (San
Diego, CA) or Miltenyi (Bergisch Gladbach, Germany).
Antibody-conjugated microbeads used for isolating cells
were from Miltenyi (Bergisch Gladbach, Germany).
Epicutaneous sensitization
Mice were sensitized as previously described [9]. Briefly,
20 μL of OVA (100 mg/mL) was placed on the disc of a
Finn chamber (Epitest, Finland). This disk was applied to
an area of shaved skin on the back of a mouse. During the
sensitization course, freshly prepared patches were applied
daily on days 1–5. For groups of mice that received co-
administration of curdlan, 10 μL of 25 μg/μl or 50 μg/μl
curdlan suspensions were added to each Finn chamber
disc. For groups of mice that received co-administration of
Pam3CSK4 or zymosan, 10 μL of Pam3CSK4 (0.5 μg/μL)
or zymosan (2 μg/μL) were added.
Cytokines in supernatants of reactivation cultures
Ten days after beginning the sensitization course, mice
were sacrificed and axillary, subscapular, and inguinal
lymph nodes (LNs) were harvested. Pooled LN cells
(1×106) were cultured in the presence or absence of
100 μg/mL OVA. Supernatants were harvested 48 h later
and stored at −80°C. IFN-γ, IL-5, IL-13, and IL-17 in super-
natants were measured by standard sandwich ELISAs.
Detection limits for IL-5, IL-13, and IL-17 were 10 pg/mL,
and the limit for IFN-γ was 50 pg/mL. OVA-specific cyto-
kine production was calculated by subtracting cytokine
production measured in the absence of OVA from that in
the presence of OVA.
Flow cytometric analysis of DC subsets in draining LNs
Skin-draining LNs were excised at 24 or 96 hours after the
start of the sensitization course. LN cell suspensions were
prepared by digestion with 2.5 mg/ml collagenase for
30 min at 37°C, the tissue was ground, then resuspended
in HBSS containing 10 mM EDTA for another 5 minutes.
CD11c+ cells were isolated using anti-CD11c microbeads.
Cells were stained using various combinations of the
following antibodies: CD11c-APC (HL3), CD103-FITC
(2E7), mPDCA-1-PE (JF 05-1C 2.4.1), B220-biotin (RA3-
6B2), MHC class II-PE-cy5 (2 G9), CD8-biotin (53–6.7),
CD40-biotin (3/23), CD80-biotin (16-10A1), CD86-biotin
(PO3), CD24-biotin (M1/69) and their isotype controls
with or without subsequent staining with streptavidin-
APC or streptavidine-PE. Intracellular staining for anti-
langerin (CD207)-PE was also done.
Total RNA extraction, cDNA preparation and quantitative
real-time PCR
Skin was obtained at 2, 4, and 24 hours after patch ap-
plication. Draining LNs were obtained at 24, 48, 72, and
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were obtained 0.5, 2, 4 and 24 hours after in vitro
culture. These were frozen with liquid nitrogen and
soaked in 1 ml TRIzol Reagent (Invitrogen, CA,). After
homogenization, total RNA was extracted, cDNA was
synthesized and the expressions of mRNA for IFN-γ,
IL-4, IL-6, IL-10, IL-12 (p35), IL-12 (p40), IL-18, IL-23,
TGF-β, IL-1α, IL-1β, and TNF-α were determined by
quantitative real-time PCR according to the manufac-
turer’s instructions. Each sample was analyzed in dupli-
cate. Relative cytokine mRNA expression levels were
normalized to β-actin expressions.
Adoptive transfer
For adoptive transfer of OVA-TCR CD4 T cells, spleen
cells from DO.11.10 mice were positively selected for
CD4 T cells using CD4 microbeads. Then, 107 CD4 T
cells/ml were incubated with 1 μM CFSE for 10 min at
37°C. Pre-warmed FCS-containing PBS was added and
then washed with cold PBS. Labeled OVA-TCR CD4 T
cells (5×106) were intravenously injected into BALB/c
recipients 3 days after the start of the sensitization
course. Draining LNs were harvested 3 days after trans-
fer. Flow cytometric analysis was used after surface
staining for CD4 or intracellular staining for IL-4.
Results
Co-administration of a dectin-1 agonist suppresses the
predominant Th2 response induced by epicutaneous
sensitization with protein antigen
Curdlan is a (1–3) β-glucan that specifically activates
dectin-1 signaling. To examine the effects of a dectin-1
agonist on epicutaneous sensitization with protein anti-
gen, we used a well-established murine protein-patch
model and co-administered doses of curdlan along with
OVA by patch application. Ten days after beginning the
sensitization course, LN cell OVA reactivation cultures
were performed and cytokine contents in supernatants
were measured to determine the direction and ampli-
tude of induced OVA-specific Th responses.
As expected, compared with the PBS control group,
mice that received OVA patch applications showed
markedly higher IL-5 and IL-13 levels in culture super-
natants (Figure 1A). Two groups of mice that received
co-administration of varying doses of curdlan along with
OVA showed lower IL-5 and IL-13 levels in culture
supernatants compared to mice that received OVA alone
(Figure 1A). The IFN-γ and IL-17 levels in supernatants
from groups of mice that received OVA plus curdlan
varied (data not shown). They were mostly lower than
mice that received OVA alone. However, higher IFN-γ and
IL-17 levels than mice receiving OVA alone were
occasionally detected. Nevertheless, lower IL-5 and
IL-13 levels in supernatants compared to mice receivingOVA alone were always detected despite variation of IFN-
γ and IL-17 levels. Mice that received curdlan alone with-
out OVA had levels of IFN-γ, IL-5, IL-13, and IL-17 in
supernatants similar to PBS controls (data not shown).
Zymosan is a mixture of (1–3) and (1–6) β-glucans
and is a stimulus for both dectin-1 and TLR2 [20]. The
importance of the collaboration between these 2 recep-
tors for regulating induced Th responses has been
emphasized [20]. Therefore, we checked the effects of
co-administering Pam3CSK4 (TLR2 agonist) plus cur-
dlan (dectin-1 agonist), as well as zymosan, on epicuta-
neous sensitization with OVA. The effect of Pam3CSK4
alone on OVA epicutaneous sensitization has been
tested in our previous study, co-administration of
Pam3CSK4 with OVA showed a modest increase of
OVA-specific Th2 response when compared with patch
application with OVA alone. As shown in Figure 1B,
compared to mice that received OVA alone, the groups
of mice that were co-administered Pam3CSK4 plus
doses of curdlan along with OVA had lower IL-5 and IL-
13 levels in the supernatants of LN cell OVA reactiva-
tion cultures. Mice that were co-administered zymosan
with OVA also had lower IL-5 and IL-13 levels than the
mice that received OVA alone. The levels of IFN-γ and
IL-17 in the supernatants for these groups of mice were
again variable compared to mice that received OVA alone
(data not shown). Taken together, these results indicate
that co-administration of a dectin-1 agonist, including cur-
dlan and zymosan, suppresses the predominant Th2 re-
sponse induced by epicutaneous sensitization with protein
antigen.
Co-administration of a dectin-1 agonist decreases the
expression levels of IL-4 and IL-1β in draining LNs
Cytokine expression patterns in the microenvironmental
milieu at sites of T cell priming orchestrate the direction
and amplitude of induced Th responses. Thus, in order
to explore the underlying mechanisms of suppressive ef-
fect of curdlan co-administration, we sought to analyze
the cytokine expression profiles in draining LNs at 24,
48, 72, and 96 hours after epicutaneous sensitization.
IFN-γ, as well as IL-12, and IL-4 are generally regarded
as the key cytokines that direct Th1 and Th2 responses,
respectively, whereas IL-6 and TGF-β are involved in
Th17 differentiation. IL-18 is unique in that it can pro-
mote either Th1 or Th2 differentiation, depending on the
presence or absence of IL-12. IL-10 and IL-1β may be par-
ticularly critical for epicutaneously-induced immune
responses [11]. In addition, we checked the mRNA ex-
pression levels of pro-inflammatory cytokines, including
IL-1α and TNF-α. As shown in Figure 2, the mRNA ex-
pression levels of IL-4 in draining LNs increased gradually
after the start of epicutaneous sensitization with OVA.
The IL-4 expression levels of mice that received OVA plus
Figure 1 Co-administration of dectin-1 agonists suppresses the epicutaneously OVA-induced Th2 immune response. (A) Groups of
BALB/c mice (n=5) were sensitized by patch application with OVA plus doses of curdlan or OVA alone on day1-5. (B) Groups of BALB/c mice
(n=5) were sensitized by patch application with OVA plus zymosan, OVA plus Pam3CSK4 and doses of curdlan, or OVA alone on day 1–5. Ten
days after the start of the sensitization course, draining LNs were obtained. The IL-5 and IL-13 contents in supernatants of in vitro OVA
reactivation culture of LN cells were determined by ELISA. Net concentrations (concentration in the absence of OVA subtracted from
concentration in the presence of OVA) were presented. Data are representative of at least three independent experiments.
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received OVA alone. The difference reached statistical sig-
nificance at 48 hr timepoint (p=0.008). Mice that received
OVA plus curdlan also showed a trend of lower IL-1β ex-
pression levels than mice that received OVA alone, but
the differences only approached statistical significance atFigure 2 Co-administration of curdlan with OVA influences the cytoki
sensitized by patch application with OVA plus curdlan or OVA alone. Drain
Total RNA extraction, cDNA preparation and quantitative real-time PCR for
expression of each group was normalized to its β-actin expression. Results
independent experiments. P values was calculated by Wilcoxon Rank Sum96 hr timepoint (p=0.073). The expression levels of IFN-γ,
IL-12 (p35), IL-12 (p40), IL-6, TGF-β, IL-18, IL-1α, and
TNF-α in draining LNs at 24, 48, 72, and 96 hours post-
sensitization were similar between these 2 groups (data
not shown). Thus, co-administering curdlan during epicu-
taneous OVA sensitization decreased the IL-4 and IL-1βne expression profiles in draining LNs. Groups of BALB/c mice were
ing LNs were obtained at 24, 48, 72 and 96 hours after sensitization.
various cytokines were performed. The relative cytokine mRNA
are shown as means and standard deviations of pooled data from five
test.
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suppressive effect on induced Th2 response.
Co-administration of a dectin-1 agonist decreases the
migration of epidermal Langerhans cell into draining LNs
The migration and activation of DCs also play a central role
in T cell priming. Therefore, we analyzed the numbers and
characteristics of skin-derived migratory DCs in draining
LNs. Skin-derived migratory DCs express the highest levels
of MHC class II molecules in draining LNs and are divided
into 3 subsets: epidermal Langerhans cells (LC; langerin+
CD103-) , dermal langerin+ DCs (langerin+ CD103+), and
dermal langerin- DCs. Dermal langerin+ DCs arrive at
draining LNs significantly earlier than epidermal LCs, with
peak influxes at 24 and 96 hours post-epicutaneous
sensitization, respectively [21]. We did not check dermal
langerin- DCs, as there are no trustworthy markers for this
subset. Blood-derived, LN-resident DC subsets, including
CD8+ DCs (CD8+ MHC class II medium) and plasmacytoid
DCs (mPDCA-1+ B220+), were also analyzed as references.
The total numbers of CD11c+ DCs in draining LNs at 24
or 96 hours after epicutaneous sensitization were similar
between mice that received OVA alone or mice that
received OVA plus curdlan (data not shown). The numbers
of epidermal LC (langerin+ CD103-) in draining LNs were
similar between these 2 groups at 24 hours after epicuta-
neous sensitization. However, at 96 hours after epicuta-
neous sensitization, the numbers of epidermal LCs of mice
that received OVA plus curdlan were significantly lower
than for mice that received OVA alone (p=0.05)
(Figure 3A). The numbers of dermal langerin+ DC (lan-
gerin+ CD103+), CD8+ DC (CD8+ MHC class II medium),
plasmacytoid DC (mPDCA-1+ B220+) were similar be-
tween the 2 groups of mice at 24 and 96 hours after epicu-
taneous sensitization (data not shown).Figure 3 Co-administration of curdlan decreases the number of epide
sensitization. (A) Groups of BALB/c mice were sensitized by patch applica
application, draining LNs were obtained and prepared for positive selection
CD103 were performed. Langerin+ CD103- cells represent epidermal LCs. Th
independent experiments. (B) 96 hours after patch application, intracellular
costimulatory molecules were performed. Langerin+ CD103- cells were gate
line), OVA plus curdlan group (black line), isotype control (gray dotted line)We next checked the expressions of co-stimulatory
molecules on langerin+ CD103- epidermal LCs in drain-
ing LNs at 96 hours after epicutaneous sensitization. As
shown in Figure 3B, the expression levels of CD86 and
CD40 were comparable between the 2 groups of mice.
The expression levels of CD80 and CD24 were also
comparable. Taken together, these results indicate that
co-administering a dectin-1 agonist during epicutaneous
sensitization with protein antigen results in decreased
migration of epidermal LCs into draining LNs without
modulating their expressions of co-stimulators.
Co-administration of a dectin-1 agonist decreases the
expression levels of IL-18 and IL-1β in patched skin
It has been reported that IL-18 induces LC migration by
a TNF-α and IL-1β-dependent mechanism [22,23]. Thus,
to explore the underlying mechanism decreasing the mi-
gration of epidermal LCs, we next checked the effect of
curdlan co-administration with OVA on the expression
levels of these cytokines in patched skin. As shown in
Figure 4, the mRNA expression levels of IL-18 and IL-1β
had already increased 2 hours after OVA patch applica-
tion. Mice that received OVA plus curdlan showed a
trend of lower expression levels of IL-18 in patched skin
than mice that received OVA alone at 2, 4, and 24 hours
after patch application. Mice that received OVA plus
curdlan also showed a trend of lower expression levels
of IL-1β at 2 and 4 hours after patch application. How-
ever, the differences didn’t reach statistical significance.
The expression levels of TNF-α as well as IL-1α, IL-6
and TGF-β in patched skin showed no significant differ-
ences between the 2 groups of mice (data not shown).
To further elucidate the target cell of the effects of cur-
dlan in patched skin, primary keratinocytes purified
from the epidermis of naïve BALB/c mice were culturedrmal LC in draining LNs at 96 hours post-epicutaneous
tion with OVA plus curdlan or OVA alone. 24 and 96 hours after patch
for DCs. Intracellular staining for langerin and surface staining for
e results were shown as mean ± SD of pooled data from four
staining for langerin and surface staining for CD103 and various
d. Expression levels of CD86 and CD40 were shown. OVA group (gray
.
Figure 4 Co-administration of curdlan with OVA influences the cytokine expression profiles in patched skin. Groups of BALB/c mice were
sensitized by patch application with OVA plus curdlan or OVA alone. Patched skins were excised 2, 4 and 24 hours after patch application. Total RNA
extract, cDNA preparation and quantitative real-time PCR for various cytokines were performed. The relative cytokine mRNA expression of each group
was normalized to its β-actin expression. Results are shown as means and standard deviations of pooled data from four independent experiments.
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cytokine expression levels were measured at 0.5, 2, 4,
and 24 hours after the start of culture. Figure 5 shows
that the expression levels of IL-1β as well as IL-1α
increased after the start of keratinocyte culture. The
presence of curdlan in the culture media seemed mod-
estly decreasing the expression levels of IL-1β and IL-1α.
However, only the difference of expression level of IL-1α
at 2 hr timepoint approached statistical significance
(p=0.071). In contrast, the expression levels of IL-18 and
TNF-α, IL-6 and TGF-β decreased gradually after the
start of keratinocyte culture and their expression levels
were comparable in the absence or presence of curdlan
(data not shown). Collectively, these results showed that
curdlan co-administration modulated the cytokine ex-
pression levels of patched skin, that might contribute to
its decreasing effect on migration of epidermal LCs.
Co-administration of curdlan decreases the proliferation
and IL-4 production of specific T cells primed by
migratory epidermal LCs in draining LNs
To further explore the effects of curdlan co-administration
on epidermal LCs in vivo, CFSE-labeled OVA-specificFigure 5 Presence of curdlan in in vitro culture decreases the IL-1α an
from naïve BALB/c mice and prepared into epidermal cell suspension. Kera
vitro culture of primary keratinocytes in the absence or presence of curdlan
and 24 hours after the start of culture. Measurement of various cytokines wTCR-transgenic CD4 T cells from DO11.10 mice were
adoptively transferred into BALB/c mice at 3 days after
beginning the OVA sensitization course, a time point
when epidermal LCs arrived at draining LNs. The drain-
ing LNs were harvested 3 days after the transfer. The
division of CFSE-labeled T cells in draining LNs was
analyzed by flow cytometry. Figure 6A shows that
CFSE-labeled CD4 T cells divided rapidly in draining
LNs. Notably, mice that were co-administered curdlan
showed a significantly lower percentage of divided la-
beled CD4 T cells compared to mice that received OVA
alone (Figure 6B). The difference approached statistical
significance (p=0.06). Moreover, intracellular IL-4 stain-
ing showed that mice that were co-administered curdlan
had fewer IL-4-producing labeled CD4 T cells than mice
that received OVA alone (p=0.045; Figure 6C). In con-
trast, when CFSE-labeled OVA-specific TCR-transgenic
CD4 T cells were adoptively transferred 1 day before the
start of the sensitization course, mice that received
OVA plus curdlan had a comparable percentage of
divided labeled CD4 T cells to that of mice that received
OVA alone (data not shown). Thus, co-administration
of curdlan decreased the proliferation and IL-4 productiond IL-1β expressions of primary keratinocytes. Skin was obtained
tinocytes were purified by negative selection with MHC class II bead. In
(50 μg/ml) were performed. Keratinocytes were harvested 0.5, 2, 4
ere performed similar to Figure 4.
Figure 6 Co-administration of curdlan decreases the proliferation and IL-4 production of specific T cells primed by epidermal LCs.
CFSE-labeled CD4 T cell from DO.11.10 mice were intravenously transferred into groups of BALB/c mice three days after they received patch
application with OVA plus curdlan or OVA alone. Draining LNs were obtained three days after transfer. (A) After staining with CD4, flow
cytometric analysis was performed. CD4+ CFSE+ cells were gated. (B) Pooled results of percentages of divided, labeled CD4 T cells of individual
mouse from three independent experiments (n=12) were shown. (C) With intracellular staining for IL-4, pooled results of numbers of IL-4-
producing, labeled CD4 T cells of individual mouse from two independent experiments were shown (n=8).
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Discussion
In this study, we demonstrated that concurrent exposure
to a dectin-1 agonist could suppress the predominant
Th2 response induced by epicutaneous sensitization with
protein antigen. We also showed that co-administering a
dectin-1 agonist influenced the cytokine expression pro-
files in draining LNs and decreased the migration of epi-
dermal LCs. To our knowledge, the effects of fungal
components on epicutaneous sensitization with protein
antigen have not been previously reported.
The effect of dectin-1 signaling on the activation of
DCs has been investigated using in vitro culture systems.
Carmona et al. and LeibundGut-Landmaun et al. both
reported that adding a dectin-1 agonist to DC culture
activated the DCs, as reflected by increased surface
expressions of CD80, CD86, and CD40 [17,18]. At first
glance, our results showing a comparable expression of
co-stimulators on LCs in draining LNs would seem to
be in conflict with previous reports. However, dectin-1
was shown to be expressed on langerin- dermal DCs,
but not langerin+ epidermal LCs [24]. In addition, al-
though epidermal keratinocytes do not constitutively ex-
press dectin-1, it can be induced by β-glucan [25].
Therefore, in our experimental system, epidermal LCscould not directly respond to co-administered curdlan.
Instead, they were indirectly influenced by cytokines that
were released by surrounding keratinocytes that
responded to curdlan via their induced dectin-1. More-
over, IL-18 and IL-1β have been shown to govern epider-
mal LC migration from the epidermis into draining LNs
[22,23]. Our results showing decreased expressions of
IL-18 and IL-1β in the patched skin of mice that were
co-administered curdlan with OVA are in agreement
with the decreased migration of epidermal LCs into
draining LNs.
Among all of the cytokines analyzed, IL-18 is always the
most abundantly expressed in skin. IL-18, a member of
the IL-1 family, is produced as a biologically inactive pre-
cursor and becomes active after its cleavage by caspase-1
[26]. Keratinocytes constitutively express IL-18 and the
IL-18 receptor [27]. The expression levels of IL-18 by ker-
atinocytes are up-regulated when exposed to double-
stranded RNA, β-defensin, and cathelicidin, whereas its
expression is suppressed by vitamin D3 [28-30]. Function-
ally, IL-18 can induce CXCL10 production by kerati-
nocytes, IL-4 and IL-13 secretion by mast cells and
basophils, and the migration of epidermal LCs [24,31,32].
Moreover, AD-like inflammatory skin lesions develop
spontaneously in transgenic mice that overexpress mature
IL-18 in their skin [33]. Single nucleotide polymorphisms
of the IL-18 gene have been shown to be associated with
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expressions in patched skin and decreased migration of
epidermal LCs into draining LNs when curdlan was co-
administered with OVA are in agreement with a lower
level of induced Th2 response. Moreover, our results
that showed no significant differences of IL-18 expres-
sions in the draining LNs between OVA and OVA plus
curdlan groups support the notion that IL-18 does not
play a critical role at the priming site during epicuta-
neous sensitization with protein antigen.
The expression level of IL-1β by epidermal keratinocytes
is one of the decisive factors for generating protective Th1
immunity during experimental Leishmaniasis, along with
IL-12, IL-4, IL-6, and osteopontin [35]. After OVA patch
application, the mRNA expression levels of IL-1α, IL-1β,
IL-6, IL-18, and TGF-β of patched skin increased rapidly
when compared with naïve BALB/c mice, whereas the
expressions of TNF-α and IL-23 were at levels similar to
naïve mice (data not shown). We could not detect any sig-
nificant expressions of IFN-γ, IL-4, IL-10, IL-12 (p35), or
IL-12 (p40) in patched skin. The lack of IL-4 and IL-12
expressions in patched skin might contribute to the pre-
dominant Th2 responses. The significance of the induced
expressions of IL-1α, IL-1β, and IL-6 in OVA-patched skin
is obscure at present. However, we suggest that they func-
tion as potentiators and enhancers of cutaneous inflam-
matory responses, similar to IL-18.
The effects of fungal components on adaptive immun-
ity has been investigated using in vivo systems. Dillon
et al. reported that zymosan induced regulatory APCs
and immunological tolerance in an experimental mouse
system using immunization by intravenous injections of
zymosan plus OVA [36]. Karumuthil-Melethil et al.
reported that treating pre- and early hyperglycemic
NOD mice with zymosan resulted in suppressing insu-
litis, leading to a significant delay in hyperglycemia [37].
Both reports showed that zymosan treatment-induced
suppression was associated with enhanced suppressor
functions of CD4+CD25+ T regulatory cells, which pro-
duced large amounts of IL-10 upon activation. Our
results showing suppression of a predominant Th2 re-
sponse are in agreement with these observations, al-
though we did not detect large amounts of IL-10 in LN
cell or splenocyte reactivation cultures (data not shown).
In contrast, Yoshitomi et al. reported that a single intra-
peritoneal injection of zymosan could trigger severe
chronic arthritis in SKG mice, which failed to develop
the disease in microbially clean conditions [38]. More-
over, Kobayashi et al. reported that an asthma-related
environmental fungus, Alternaria, produced potent Th2
adjuvant effects in the airways [39]. Possible reasons for
the remarkable discrepancies between this report and
our results are the following. First, Th2 skewing is stron-
ger and absolute with epicutaneous sensitization, whileit is only preferential with inhalation priming, as evi-
denced by detectable antigen-specific IgE in only a mi-
nority of inhalation-sensitized mice and that some mice
also exhibited antigen-specific IgG2a responses [30].
Second, marked differences in the IL-4 and IL-13 de-
pendencies of Th2 responses generated on the skin or in
the airways have been emphasized [40]. Third, the study
by Kobayashi et al. used fungal extracts that may have
induced signaling other than dectin-1. Fourth, during in-
halation sensitization, fungal elements can be
approached by dectin-1 expressing macrophages and
DCs in the alveoli, which is quite a different situation
from non-dectin-1-expressing epidermal LCs in the skin.
Conclusion
Concurrent exposure to a dectin-1 agonist could sup-
press the predominant Th2 immune response induced
by epicutaneous sensitization with a protein antigen by
decreasing the migration of epidermal LCs and influen-
cing the cytokine profiles of draining LNs. These results
provide useful information for the prevention and con-
trol of allergen sensitization in atopic diseases.
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